{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:13:04Z","timestamp":1768410784967,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jhep.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T04:15:04Z","timestamp":1442117704000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pros and Cons: Usage of organs from donors infected with hepatitis C virus \u2013 Revision in the direct-acting antiviral era"],"prefix":"10.1016","volume":"64","author":[{"given":"Audrey","family":"Coilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.09.002_b0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(95)90579-0","article-title":"Dilemmas of organ transplantation from anti-HCV-positive donors","volume":"345","author":"Sanchez-Tapias","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.09.002_b0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/liv.12728","article-title":"Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals","volume":"35","author":"Coilly","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.09.002_b0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamasurg.2014.2038","article-title":"Survival benefit of solid-organ transplant in the United States","volume":"150","author":"Rana","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhep.2015.09.002_b0020","unstructured":"Annual Review of the Biomedicine Agency. <http:\/\/wwwagence-biomedecinefr\/annexes\/bilan2013\/donnees\/organes\/05-foie\/synthesehtm>, 2013."},{"key":"10.1016\/j.jhep.2015.09.002_b0025","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.transproceed.2012.05.065","article-title":"A preliminary European study on extended-criteria liver donation and transplant recipient consent","volume":"44","author":"Bruzzone","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2015.09.002_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from anti-hepatitis B core positive donors: a systematic review","volume":"52","author":"Cholongitas","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.09.002_b0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.09.002_b0040","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF00867679","article-title":"Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste","volume":"9","author":"Pereira","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jhep.2015.09.002_b0045","unstructured":"Annual Review of the Biomedicine Agency. <http:\/\/wwwagence-biomedecinefr\/annexes\/bilan2010\/donnees\/organes\/11-bilan\/synthese>, 2011."},{"key":"10.1016\/j.jhep.2015.09.002_b0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1399-0012.2000.14040602.x","article-title":"Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors","volume":"14","author":"Mandal","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2015.09.002_b0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1600-6143.2011.03460.x","article-title":"Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","author":"Kucirka","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2015.09.002_b0060","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","author":"Suryaprasad","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2015.09.002_b0065","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study","volume":"91","author":"Ballarin","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2015.09.002_b0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1432-2277.2012.01498.x","article-title":"Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined","volume":"25","author":"O\u2019Leary","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2015.09.002_b0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.21734","article-title":"Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors","volume":"82","author":"Meffre","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.09.002_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1034\/j.1399-3062.2002.t01-2-01002.x","article-title":"Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus)","volume":"4","author":"Natov","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhep.2015.09.002_b0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1600-6143.2002.20508.x","article-title":"Hepatitis C-positive donors in heart transplantation","volume":"2","author":"Marelli","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2015.09.002_b0090","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.510290412","article-title":"Recurrent and new hepatitis C virus infection after liver transplantation","volume":"29","author":"Everhart","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.09.002_b0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2015.09.002_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/jhep.2003.50264","article-title":"Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains","volume":"38","author":"Fan","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.09.002_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0016-5085(99)70561-5","article-title":"Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts","volume":"117","author":"Vargas","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.09.002_b0110","first-page":"1469","article-title":"Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation","volume":"25","author":"Aeder","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2015.09.002_b0115","first-page":"1204","article-title":"Use of anti-hepatitis C virus seropositive organs in liver transplantation","volume":"27","author":"Mulligan","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2015.09.002_b0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-8278(05)80270-3","article-title":"Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test","volume":"18","author":"Shah","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.09.002_b0125","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0016-5085(99)70420-8","article-title":"Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients","volume":"117","author":"Torres","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.09.002_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0016-5085(99)70577-9","article-title":"Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients?","volume":"117","author":"Feray","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.09.002_b0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/jlts.2001.27088","article-title":"Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers","volume":"7","author":"Marroquin","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.09.002_b0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00007890-200202270-00018","article-title":"The outcome of liver grafts procured from hepatitis C-positive donors","volume":"73","author":"Velidedeoglu","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2015.09.002_b0145","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/lt.20849","article-title":"Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts","volume":"12","author":"Khapra","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.09.002_b0150","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.transproceed.2005.06.004","article-title":"Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience","volume":"37","author":"Ricchiuti","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2015.09.002_b0155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.transproceed.2012.05.012","article-title":"Liver transplantation from anti-hepatitis C virus-positive donors: our experience","volume":"44","author":"Alvaro","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2015.09.002_b0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1034\/j.1600-6143.2003.00189.x","article-title":"Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis","volume":"3","author":"Saab","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2015.09.002_b0165","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00007890-199804150-00011","article-title":"Long-term outcome of patients transplanted with livers from hepatitis C-positive donors","volume":"65","author":"Testa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2015.09.002_b0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00000658-200109000-00012","article-title":"A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients","volume":"234","author":"Ghobrial","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2015.09.002_b0175","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis","volume":"23","author":"Northup","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2015.09.002_b0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.09.002_b0185","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hep.22484","article-title":"Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection","volume":"48","author":"Hoare","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.09.002_b0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/lt.23396","article-title":"Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study","volume":"18","author":"Lai","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.09.002_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/liv.12062","article-title":"Current management and perspectives for HCV recurrence after liver transplantation","volume":"33","author":"Coilly","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.09.002_b0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.09.002_b0205","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.27681","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation","volume":"61","author":"Forns","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.09.002_b0210","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jhep.2015.09.002_b0215","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.cgh.2015.05.030","article-title":"Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation","volume":"13","author":"Leroy","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.09.002_b0220","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","volume":"61","author":"Pungpapong","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2015.09.002_b0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jhep.2015.09.002_b0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jvh.12419","article-title":"Therapy for hepatitis C genotype 3: moving forward","volume":"22","author":"Buti","year":"2015","journal-title":"J Viral Hepat"},{"issue":"11","key":"10.1016\/j.jhep.2015.09.002_b0235","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jmv.24255","article-title":"Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy","volume":"87","author":"Yoshimi","year":"2015","journal-title":"J Med Virol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815006170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815006170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:51:24Z","timestamp":1537361484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815006170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0168827815006170"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.09.002","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pros and Cons: Usage of organs from donors infected with hepatitis C virus \u2013 Revision in the direct-acting antiviral era","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}